Literature DB >> 9163289

Complete sustained response of a refractory, post-transplantation, large B-cell lymphoma to an anti-CD22 immunotoxin.

A M Senderowicz1, E Vitetta, D Headlee, V Ghetie, J W Uhr, W D Figg, R M Lush, M Stetler-Stevenson, G Kershaw, D W Kingma, E S Jaffe, E A Sausville.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9163289     DOI： 10.7326/0003-4819-126-11-199706010-00005

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

Review 1.  Immunotoxins for targeted cancer therapy.

Authors:  Robert J Kreitman
Journal:  AAPS J       Date:  2006-08-18       Impact factor: 4.009

2.  Transition state analogues in structures of ricin and saporin ribosome-inactivating proteins.

Authors:  Meng-Chiao Ho; Matthew B Sturm; Steven C Almo; Vern L Schramm
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-17       Impact factor: 11.205

3.  Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones.

Authors:  M Tommasi; D Castelletti; M Pasti; G Fracasso; I Lorenzetti; S Sartoris; C Pera; G B Ferrara; G Tridente; M Colombatti
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

Review 4.  Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD).

Authors:  M A Nalesnik
Journal:  Springer Semin Immunopathol       Date:  1998

Review 5.  Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies.

Authors:  Robert J Kreitman
Journal:  BioDrugs       Date:  2009       Impact factor: 5.807

Review 6.  Post-transplant malignancy: the role of immunosuppression.

Authors:  I Penn
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.228
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.